<VariationArchive VariationID="550946" VariationName="NM_001130987.2(DYSF):c.1471dup (p.Met491fs)" VariationType="Duplication" Accession="VCV000550946" Version="12" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-17" DateCreated="2018-08-05" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="542254" VariationID="550946">
      <GeneList>
        <Gene Symbol="DYSF" FullName="dysferlin" GeneID="8291" HGNC_ID="HGNC:3097" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71453561" stop="71686763" display_start="71453561" display_stop="71686763" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71680752" stop="71913892" display_start="71680752" display_stop="71913892" Strand="+" />
          </Location>
          <OMIM>603009</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001130987.2(DYSF):c.1471dup (p.Met491fs)</Name>
      <CanonicalSPDI>NC_000002.12:71535283:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71535283" stop="71535284" display_start="71535283" display_stop="71535284" variantLength="1" positionVCF="71535283" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71762413" stop="71762414" display_start="71762413" display_stop="71762414" variantLength="1" positionVCF="71762413" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>M459fs</ProteinChange>
      <ProteinChange>M490fs</ProteinChange>
      <ProteinChange>M460fs</ProteinChange>
      <ProteinChange>M491fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.71762419dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.71762419dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.71535289dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.71535289dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008694.1" sequenceAccession="NG_008694" sequenceVersion="1" change="g.86667dup">
            <Expression>NG_008694.1:g.86667dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130455.2" sequenceAccession="NM_001130455" sequenceVersion="2" change="c.1378dup">
            <Expression>NM_001130455.2:c.1378dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001123927.1" sequenceAccession="NP_001123927" sequenceVersion="1" change="p.Met460fs">
            <Expression>NP_001123927.1:p.Met460fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130976.2" sequenceAccession="NM_001130976" sequenceVersion="2" change="c.1375dup">
            <Expression>NM_001130976.2:c.1375dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124448.1" sequenceAccession="NP_001124448" sequenceVersion="1" change="p.Met459fs">
            <Expression>NP_001124448.1:p.Met459fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130977.2" sequenceAccession="NM_001130977" sequenceVersion="2" change="c.1375dup">
            <Expression>NM_001130977.2:c.1375dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124449.1" sequenceAccession="NP_001124449" sequenceVersion="1" change="p.Met459fs">
            <Expression>NP_001124449.1:p.Met459fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130978.2" sequenceAccession="NM_001130978" sequenceVersion="2" change="c.1375dup">
            <Expression>NM_001130978.2:c.1375dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124450.1" sequenceAccession="NP_001124450" sequenceVersion="1" change="p.Met459fs">
            <Expression>NP_001124450.1:p.Met459fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130979.2" sequenceAccession="NM_001130979" sequenceVersion="2" change="c.1468dup">
            <Expression>NM_001130979.2:c.1468dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124451.1" sequenceAccession="NP_001124451" sequenceVersion="1" change="p.Met490fs">
            <Expression>NP_001124451.1:p.Met490fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130980.2" sequenceAccession="NM_001130980" sequenceVersion="2" change="c.1468dup">
            <Expression>NM_001130980.2:c.1468dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124452.1" sequenceAccession="NP_001124452" sequenceVersion="1" change="p.Met490fs">
            <Expression>NP_001124452.1:p.Met490fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130981.2" sequenceAccession="NM_001130981" sequenceVersion="2" change="c.1468dup">
            <Expression>NM_001130981.2:c.1468dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124453.1" sequenceAccession="NP_001124453" sequenceVersion="1" change="p.Met490fs">
            <Expression>NP_001124453.1:p.Met490fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130982.2" sequenceAccession="NM_001130982" sequenceVersion="2" change="c.1471dup">
            <Expression>NM_001130982.2:c.1471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124454.1" sequenceAccession="NP_001124454" sequenceVersion="1" change="p.Met491fs">
            <Expression>NP_001124454.1:p.Met491fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130983.2" sequenceAccession="NM_001130983" sequenceVersion="2" change="c.1378dup">
            <Expression>NM_001130983.2:c.1378dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124455.1" sequenceAccession="NP_001124455" sequenceVersion="1" change="p.Met460fs">
            <Expression>NP_001124455.1:p.Met460fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130984.2" sequenceAccession="NM_001130984" sequenceVersion="2" change="c.1378dup">
            <Expression>NM_001130984.2:c.1378dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124456.1" sequenceAccession="NP_001124456" sequenceVersion="1" change="p.Met460fs">
            <Expression>NP_001124456.1:p.Met460fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130985.2" sequenceAccession="NM_001130985" sequenceVersion="2" change="c.1471dup">
            <Expression>NM_001130985.2:c.1471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124457.1" sequenceAccession="NP_001124457" sequenceVersion="1" change="p.Met491fs">
            <Expression>NP_001124457.1:p.Met491fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130986.2" sequenceAccession="NM_001130986" sequenceVersion="2" change="c.1378dup">
            <Expression>NM_001130986.2:c.1378dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124458.1" sequenceAccession="NP_001124458" sequenceVersion="1" change="p.Met460fs">
            <Expression>NP_001124458.1:p.Met460fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130987.2" sequenceAccession="NM_001130987" sequenceVersion="2" change="c.1471dup" MANESelect="true">
            <Expression>NM_001130987.2:c.1471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124459.1" sequenceAccession="NP_001124459" sequenceVersion="1" change="p.Met491fs">
            <Expression>NP_001124459.1:p.Met491fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003494.4" sequenceAccession="NM_003494" sequenceVersion="4" change="c.1375dup" MANEPlusClinical="true">
            <Expression>NM_003494.4:c.1375dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003485.1" sequenceAccession="NP_003485" sequenceVersion="1" change="p.Met459fs">
            <Expression>NP_003485.1:p.Met459fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_845" sequenceAccession="LRG_845">
            <Expression>LRG_845:g.86667dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_845t2" sequenceAccession="LRG_845t2">
            <Expression>LRG_845t2:c.1471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_845p2" sequenceAccession="LRG_845p2" change="p.Met491fs">
            <Expression>LRG_845p2:p.Met491fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_845t1" sequenceAccession="LRG_845t1">
            <Expression>LRG_845t1:c.1375dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_845p1" sequenceAccession="LRG_845p1" change="p.Met459fs">
            <Expression>LRG_845p1:p.Met459fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003494.3" sequenceAccession="NM_003494" sequenceVersion="3" change="c.1375dupA">
            <Expression>NM_003494.3:c.1375dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003494.4" sequenceAccession="NM_003494" sequenceVersion="4" change="c.1375dupA" MANEPlusClinical="true">
            <Expression>NM_003494.4:c.1375dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1236367931" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001130987.2(DYSF):c.1471dup (p.Met491fs) AND Autosomal recessive limb-girdle muscular dystrophy type 2B" Accession="RCV000665852" Version="2">
        <ClassifiedConditionList TraitSetID="1850">
          <ClassifiedCondition DB="MedGen" ID="C1850889">Autosomal recessive limb-girdle muscular dystrophy type 2B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-03-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001130987.2(DYSF):c.1471dup (p.Met491fs) AND Qualitative or quantitative defects of dysferlin" Accession="RCV001053757" Version="7">
        <ClassifiedConditionList TraitSetID="9586">
          <ClassifiedCondition DB="MedGen" ID="C2931687">Qualitative or quantitative defects of dysferlin</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001130987.2(DYSF):c.1471dup (p.Met491fs) AND Miyoshi muscular dystrophy 1" Accession="RCV003465444" Version="2">
        <ClassifiedConditionList TraitSetID="1848">
          <ClassifiedCondition DB="MedGen" ID="C4551973">Miyoshi muscular dystrophy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-22" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-08-05" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17698709</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25591676</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27647186</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29797799</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30107846</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301480</ID>
          <ID Source="BookShelf">NBK1303</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1848" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2959" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 1</ElementValue>
                <XRef ID="MONDO:0024545" DB="MONDO" />
                <XRef ID="C118846" DB="NCI" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD1</ElementValue>
                <XRef Type="MIM" ID="254130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Miyoshi Distal Myopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2017">
                <ID Source="PubMed">25313375</ID>
                <ID Source="pmc">4206155</ID>
              </Citation>
              <XRef ID="45448" DB="Orphanet" />
              <XRef ID="C4551973" DB="MedGen" />
              <XRef ID="MONDO:0024545" DB="MONDO" />
              <XRef Type="MIM" ID="254130" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9586" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9484" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dysferlinopathy</ElementValue>
                <XRef ID="Dysferlinopathy/2379" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Qualitative or quantitative defects of dysferlin</ElementValue>
                <XRef ID="MONDO:0016145" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2003" />
                <XRef ID="2003" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <XRef ID="207073" DB="Orphanet" />
              <XRef ID="C2931687" DB="MedGen" />
              <XRef ID="MONDO:0016145" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1850" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2988" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0022" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2B</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2B/4237" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2B</ElementValue>
                <XRef ID="MONDO:0009676" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LGMD3</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR2</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8574" />
                <XRef ID="8574" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <XRef ID="268" DB="Orphanet" />
              <XRef ID="C1850889" DB="MedGen" />
              <XRef ID="MONDO:0009676" DB="MONDO" />
              <XRef Type="MIM" ID="253601" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1540343" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="455373|OMIM:253601" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000790039" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27647186</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="GA" referenceAllele="G" start="71762413" stop="71762413" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003494.3:c.1375dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253601" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2873917" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_003494.4:c.1375dupA|Limb-girdle muscular dystrophy type 2B" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001458642" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003494.4:c.1375dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Limb-girdle muscular dystrophy type 2B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2383461" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4830328|MedGen:C2931687" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001218034" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25591676</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27647186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29797799</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30107846</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17698709</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301480</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 550946). This variant is also known as c.1370dupA. This premature translational stop signal has been observed in individual(s) with dysferlinopathy (PMID: 25591676, 27647186, 29797799, 30107846). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Met459Asnfs*15) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.71762413_71762414insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931687" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7847048" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_003494.4:c.1375dup|OMIM:254130" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004194242" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003494.4:c.1375dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="254130" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7847048" TraitType="Disease" MappingType="XRef" MappingValue="254130" MappingRef="OMIM">
        <MedGen CUI="C4551973" Name="Miyoshi muscular dystrophy 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1540343" TraitType="Disease" MappingType="XRef" MappingValue="253601" MappingRef="OMIM">
        <MedGen CUI="C1850889" Name="Autosomal recessive limb-girdle muscular dystrophy type 2B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2873917" TraitType="Disease" MappingType="Name" MappingValue="Limb-girdle muscular dystrophy type 2B" MappingRef="Preferred">
        <MedGen CUI="C1850889" Name="Autosomal recessive limb-girdle muscular dystrophy type 2B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2383461" TraitType="Disease" MappingType="XRef" MappingValue="C2931687" MappingRef="MedGen">
        <MedGen CUI="C2931687" Name="Qualitative or quantitative defects of dysferlin" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

